Corient Private Wealth’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66M | Sell |
95,395
-616
| -0.6% | -$23.7K | ﹤0.01% | 864 |
|
|
2025
Q1 | $3.72M | Sell |
96,011
-333
| -0.3% | -$12.9K | 0.01% | 764 |
|
|
2024
Q4 | $3.26M | Buy |
96,344
+10,895
| +13% | +$368K | 0.01% | 828 |
|
|
2024
Q3 | $3.49M | Buy |
85,449
+6,395
| +8% | +$261K | 0.01% | 844 |
|
|
2024
Q2 | $3.04M | Buy |
79,054
+4,926
| +7% | +$190K | 0.01% | 861 |
|
|
2024
Q1 | $3.18M | Buy |
74,128
+6,564
| +10% | +$281K | 0.01% | 834 |
|
|
2023
Q4 | $2.5M | Sell |
67,564
-1,014
| -1% | -$37.6K | ﹤0.01% | 904 |
|
|
2023
Q3 | $2.49M | Sell |
68,578
-129
| -0.2% | -$4.68K | 0.01% | 837 |
|
|
2023
Q2 | $2.45M | Buy |
68,707
+6,922
| +11% | +$247K | 0.01% | 835 |
|
|
2023
Q1 | $2.2M | Buy |
61,785
+29,016
| +89% | +$1.03M | 0.01% | 810 |
|
|
2022
Q4 | $1.16M | Buy |
+32,769
| New | +$1.16M | ﹤0.01% | 864 |
|